País: Països Baixos
Idioma: anglès
Font: HMA (Heads of Medicines Agencies)
amoxicillin 50 mg, clavulanic acid 12.5 mg
Vetoquinol Uk limited
QJ01CR02
Tablet
amoxicillin and enzyme inhibitor
Cats Non Food, Dogs Non Food
2013-01-23
Issued: April 2013 AN: 00043/2012 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS _ _ 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NAME COUNTRIES Clavaseptin 62.5 mg Palatable tablets for dogs and cats Belgium, Bulgaria, Cyprus, Greece, Czech Republic, Hungary, Ireland, Latvia, Lithuania, Netherlands, Poland, Romania, Slovakia, Slovenia, UK, Portugal, Spain Clavaseptin P 62.5 mg Tablets for dogs and cats France, Luxembourg Clavaseptin 62.5 mg – Tablets for dogs and cats Austria, Germany, Italy Clavaseptin 50mg/12.5mg Tablets for dogs and cats Denmark, Finland, Sweden, Norway 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains: Active ingredients: Amoxicillin (as amoxicillin trihydrate)……………….……………..………. 50.000 mg Clavulanic acid (as potassium clavulanate)…………………………..… 12.500 mg Excipients Brown iron oxide (E172)………………………………….…..…….….. 0.120 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. Beige scored tablet that can be divided into halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES IN DOGS: treatment or adjunctive treatment of periodontal infections caused by bacteria susceptible to amoxicillin in combination with clavulanic acid i.e. _Pasteurella _ spp, _Streptococcus_ spp and _Escherichia coli_. IN CATS: treatment of skin infections (including wounds and abscesses) caused by bacteria susceptible to amoxicillin in combination with clavulanic acid i Llegiu el document complet